These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39339416)

  • 1. Optimization and Synthesis of Nano-Niosomes for Encapsulation of Triacontanol by Box-Behnken Design.
    Solano AAB; Dávila-Ortiz G; de Jesús Perea-Flores M; Martínez-Ayala AL
    Molecules; 2024 Sep; 29(18):. PubMed ID: 39339416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
    Abdelbary AA; AbouGhaly MH
    Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
    Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
    Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lawsone-loaded Niosome and its antitumor activity in MCF-7 breast Cancer cell line: a Nano-herbal treatment for Cancer.
    Barani M; Mirzaei M; Torkzadeh-Mahani M; Nematollahi MH
    Daru; 2018 Sep; 26(1):11-17. PubMed ID: 30159762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of Tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs.
    Mehta SK; Jindal N
    Colloids Surf B Biointerfaces; 2013 Jan; 101():434-41. PubMed ID: 23010052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, preparation of niosome loaded zinc oxide nanoparticles and biological activities.
    Rezaei H; Iranbakhsh A; Sepahi AA; Mirzaie A; Larijani K
    Sci Rep; 2024 Jul; 14(1):16692. PubMed ID: 39030347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterisation of Span 65 niosomal formulations containing proteins.
    Haj-Ahmad RR; Elkordy AA; Chaw CS
    Curr Drug Deliv; 2015; 12(5):628-39. PubMed ID: 25963305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability.
    Zidan AS; Mokhtar Ibrahim M; Megrab NAE
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1450-1459. PubMed ID: 28420295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niosomes as carriers of radiopaque contrast agents for X-ray imaging.
    Muller D; Foulon M; Bonnemain B; Vandamme TF
    J Microencapsul; 2000; 17(2):227-43. PubMed ID: 10738698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization, optimization, and in vitro evaluation of Technetium-99m-labeled niosomes.
    De Silva L; Fu JY; Htar TT; Muniyandy S; Kasbollah A; Wan Kamal WHB; Chuah LH
    Int J Nanomedicine; 2019; 14():1101-1117. PubMed ID: 30863048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying the Taguchi method to optimize sumatriptan succinate niosomes as drug carriers for skin delivery.
    González-Rodríguez ML; Mouram I; Cózar-Bernal MJ; Villasmil S; Rabasco AM
    J Pharm Sci; 2012 Oct; 101(10):3845-63. PubMed ID: 22806266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoliposomal Encapsulation of
    Zahedi Y; Shaddel R; Salamatian M; Szumny A
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38930869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brij Niosomes as Carriers for Sustained Drug Delivery─A Fluorescence-Based Approach to Probe the Niosomal Microenvironment.
    Sarkar S; De S
    Langmuir; 2022 Apr; 38(15):4521-4537. PubMed ID: 35377656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate.
    Allam A; Fetih G
    Drug Des Devel Ther; 2016; 10():2421-33. PubMed ID: 27536063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin.
    Imran M; Shah MR; Ullah F; Ullah S; Elhissi AM; Nawaz W; Ahmad F; Sadiq A; Ali I
    Drug Deliv; 2016 Nov; 23(9):3653-3664. PubMed ID: 27886514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug.
    Sezgin-Bayindir Z; Antep MN; Yuksel N
    AAPS PharmSciTech; 2015 Feb; 16(1):108-17. PubMed ID: 25204859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
    Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
    Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system.
    Gugleva V; Titeva S; Rangelov S; Momekova D
    Int J Pharm; 2019 Aug; 567():118431. PubMed ID: 31207279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol.
    Devaraj GN; Parakh SR; Devraj R; Apte SS; Rao BR; Rambhau D
    J Colloid Interface Sci; 2002 Jul; 251(2):360-5. PubMed ID: 16290741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of noisome preparation methods in encapsulating 5-fluorouracil and real time cell assay against HCT-116 colon cancer cell line.
    Ugorji OL; Umeh ONC; Agubata CO; Adah D; Obitte NC; Chukwu A
    Heliyon; 2022 Dec; 8(12):e12369. PubMed ID: 36582708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.